| Management of the patient with advanced complications, functional decline, and persistent hyperglycemia. | |
| | |
MedLine Citation:
|
PMID: 20726377 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Current management of hypoglycemic risk among seniors with type 2 diabetes mellitus (T2DM) is frequently not very effective. Treatment guidelines with target glycosylated hemoglobin (A1C) levels provide important standards for T2DM management, but target goals must be determined on an individual basis in conjunction with individual factors, including risk of hypoglycemia. This clinical review will help pharmacists develop optimal therapeutic regimens for elderly diabetic patients that carefully balance risks and benefits of therapy, better assess their elderly patients' risk of hypoglycemia, and determine appropriate blood glucose testing schedules for the long-term care patient. DATA SOURCES: Live symposium presentation based on clinical practice and research, medical literature, and studies published between January 1998 and April 2009 on managing diabetes in older adults, government statistics, and medical society guidelines. CONCLUSIONS: When treating seniors with T2DM, it is critical that hypoglycemia be identified and avoided. Hypoglycemia, whether undiagnosed, recurring, or brought about with the use of traditional insulin or other antihyperglycemic agents with higher hypoglycemic risk, can lead to the risk of falls and injuries related to that. Certain therapeutic measures, including alterations to blood glucose testing schedules, less stringent A1C goals, and insulin analog therapies, facilitate effective glycemic control and decrease the risk of hypoglycemia. |
| | |
Authors:
|
Donald K Zettervall |
Related Documents
:
|
6343097 - Effect of fasting on posthyperglycemic glucose homeostasis in obesity--experimental mod... 8404437 - Insulinoma in a patient with niddm. 15037987 - Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. 1738397 - Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyr... 16399897 - Central and peripheral effects of insulin/igf-1 signaling in aging and cancer: antidiab... 19893307 - Baseline diabetic status and admission blood glucose were poor prognostic factors in th... |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists Volume: 25 Suppl B ISSN: 0888-5109 ISO Abbreviation: Consult Pharm Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-08-23 Completed Date: 2010-09-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9013983 Medline TA: Consult Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: 5-10 Citation Subset: IM |
Affiliation:
|
The Diabetes Center, in Old Saybrook, Connecticut 06475, USA. diabctr@sbcglobal.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Blood Glucose / drug effects Diabetes Mellitus, Type 2 / drug therapy* Female Hemoglobin A, Glycosylated / metabolism* Humans Hyperglycemia / drug therapy Hypoglycemia / chemically induced, diagnosis, prevention & control* Hypoglycemic Agents / adverse effects, therapeutic use* Pharmacists / organization & administration Practice Guidelines as Topic Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Hemoglobin A, Glycosylated; 0/Hypoglycemic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lipoma arborescens of the knee.
Next Document: Prediabetes in a nursing facility patient with renal insufficiency.